Table 2.
White | African–American HR (95% CI) |
Hispanic HR (95% CI) |
Native American HR (95% CI) |
Asian/Pacific Islander HR (95% CI) |
Wald χ | P-valuea | |
---|---|---|---|---|---|---|---|
Model 1b | 1.0 (ref) | 1.16 (0.99, 1.34) | 0.73 (0.54, 0.97) | 0.99 (0.49, 1.98) | 0.81 (0.59, 1.09) | 11.07 | 0.03 |
Model 1 + education (≥HS vs. <HS) | 1.0 (ref) | 1.17 (1.01, 1.36) | 0.76 (0.57, 1.02) | 1.01 (0.50, 2.03) | 0.79 (0.58, 1.08) | 10.64 | 0.03 |
Model 1 + history of diabetes | 1.0 (ref) | 1.12 (0.96, 1.30) | 0.71 (0.54, 0.95) | 0.95 (0.47, 1.90) | 0.80 (0.59, 1.08) | 10.13 | 0.04 |
Model 1 + lifestyle factors (BMI, physical activity, smoking, alcohol) |
1.0 (ref) | 1.09 (0.92, 1.28) | 0.75 (0.55, 1.01) | 0.93 (0.44, 1.95) | 0.92 (0.67, 1.25) | 5.26 | 0.26 |
Model 1 + NSAID use/duration | 1.0 (ref) | 1.15 (0.99, 1.34) | 0.72 (0.54, 0.96) | 0.99 (0.49, 1.99) | 0.84 (0.61, 1.15) | 11.14 | 0.03 |
Model 1 + dietary factors (total energy, fiber, red meat, fruits and vegetables) |
1.0 (ref) | 1.11 (0.94, 1.29) | 0.73 (0.54, 0.98) | 1.03 (0.51, 2.06) | 0.79 (0.57, 1.09) | 8.49 | 0.08 |
Model 1 + total calcium intake | 1.0 (ref) | 1.08 (0.92, 1.26) | 0.71 (0.53, 0.96) | 1.02 (0.51, 2.05) | 0.77 (0.56, 1.06) | 8.93 | 0.06 |
Model 1 + screening, polyp removal and family history | 1.0 (ref) | 1.19 (1.01, 1.40) | 0.70 (0.51, 0.96) | 1.05 (0.50, 2.20) | 0.83 (0.61, 1.14) | 11.32 | 0.02 |
Model 1 + hormone therapy use | 1.0 (ref) | 1.09 (0.93, 1.26) | 0.71 (0.53, 0.94) | 0.98 (0.49, 1.96) | 0.81 (0.60, 1.11) | 8.97 | 0.06 |
From a Wald χ2 4 degrees of freedom test of the main effect of race/ethnicity
Adjusted for age, and stratified on WHI trial and extension study participation.